CD19 & CD3E, Human (Blinatumomab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD19 & CD3E, Human (Blinatumomab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD19 & CD3E, Human (Blinatumomab biosimilar)
CloneBlinatumomab
Host SpeciesRecombinant
Reactive Specieshuman
Isotype(scFv kappa-heavy)-(scFv-heavy kappa)
FormatscFv fragment
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD19 & CD3E Recombinant Antibody (Blinatumomab). Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
Immunogenn/a
Other NamesAnti-CD19 & CD3E Recombinant Antibody, Research Grade Blinatumomab, Anti-Human CD19 & CD3E Recombinant Antibody(Blinatumomab), AMG103, BITE MT-103, Antibody Drug Analogues, Monoclonal Antibody, YR1047, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 853426-35-4
Catalog #YR1047
Priceplease inquire
Order / More InfoCD19 & CD3E, Human (Blinatumomab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.